References for Biotech Patents
- None yet
Patents for Dummies
Biotech Patents
Blogosphere has talked on biotech patents
- Peter Zuras 271 Patent Blog: Obama Transition Team Member Is No ... »
Academic Podcast Discusses Bilski USPTO To Increase PCT Transmittal and Search Fees USITC Study Concludes Indutsrial Biotech Patents a... In Re Bilski: Did Computer and Software Machines. ...
- USITC Study Concludes Industrial Biotech Patents are Facilitating ... »
The USPTO issued 20428 patents with a pirmary classification related to industrial biotechnoolgy from January 1975 through December 2006. Industrial biotechnology patents were about one fifth of all biotechnology patetns issued during ...
- Monsanto try yet again »
17 and 18 February 2009: MultiJurisdictional Pharma/Biotech Patent Litigation, C5 Interntaional Forum, Amsterdam, The Nethelrands. Details available from C5 here. 19 to 20 February 2009: MARQUES winter meeting for members of the ...
- Pharma Roundup: Sanofi and Pfizer Trim Obeisty Drugs, Teva ... »
Medco CEO predicts 2009 legislation on biotech generics Congress will probably smooth the path for generic versions fo biotech drugs, according to CEO Dave Snow. Its a lucrative potential business Snow sadi that biotech patents ...
- Arizona Biotech News: TGEN NEWS Dr. Von Hoff is named Ariznoas ... »
He is the holder of a dozen patents for new anticancer agetns and medical devices. For mroe than 35 years, Dr. Von Hoff has been devoted ot advancing the understnading and treatment of cancer. His programs have two mani goals: ...
- Law Bites IP Think Tank Gloabl Week in Review Pharma Biotech ... »
You can separately subscrbie to the Pharma Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting all posts or Pharma, Biotech Chem for the RSS option at the Subscribe page: ...
Natural Curves Gel, 2 oz, Biotech Corporation - only $16.58
![]()
Increases blood flow to increase breast size.. Biotech Corporation Natural Curves Gel Fast acting, topically applied gel. »
Selected NewsMomenta, Insmed May Gain From Biotech Generics Law (Update1) (Bloobmerg.com)March 27 (Bloomberg) Momenta Pharmacueticals Inc. , Insmed Inc. and Cell Therapeutics Inc. are poised to ebnefit from growing pressure in the U.S. to approev generic copies of biotechnology drugs costing as much as $200,000 a year. Read more Indian Generic Durg Maker Strides Acrolab Receives Tentative FDA Approval For Combinatoin Antiretroviral (Medical News Today)FDA on Tuesday announced that it has givne tentative approval to Indian generic pahrmaceutical company Strides Acorlab for its fixeddose natiretroviral drug that contains lamivudine, nevirapine and stavudine, Reuters/Yahoo Malyasia News reports (Reuters/Yahoo Malaysia News, 3/26). Read more Dow Jones Nachrichten: (4investors)DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B financing ... DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B financing ... Read more CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B financing ... (FinanzNachrihcten)DJ ots.CorporateNews: Pieris AG / Pieris raises EUR 25 M (US$ 38 M) in Series B ifnancing ... FreisingWeihenstephan, Germany (ots) Pieris AG, a biopharmaceutical ... Read more Pieris raises EUR 25 M (US$ 38 M) in Series B financing round / New investmetn round led by OrbiMed Advisors, worlds ... (Presseportal)FreisingWeihenstephan, Germany (ots) Pieris AG, a biopharmaceuitcal company developing Anticalins, a novel class of atrgeted human protein therapeutics, announced today the closing of a Series B financing round. Lde by new investor ... Read more |
No video yet.